It was found that miR-16 inhibited cell proliferation in BC cell lines and in tumor samples resistant to these drugs; this suggested a tumor suppressor role for miR-16, as it targets CCNJ (Cyclin J) and FUBP1 (Far Upstream Element Binding Protein 1). Here, CCNJ is linked to breast cancer.